In plasma, the biomarkers CCL17, IL‐5, VEGF‐C, GM‐CSF and CCL26 had the most significant fold increases in plasma of patients with AD compared with healthy controls, while IL‐4 and CXCL10 had the most significant decreases. The gene discussed is CCL26; the disease is Alzheimer disease.